MIDODRINE ANS, MIDODRINE SCP, VASODRINE (Southern Cross Pharma Pty Ltd)
Product name
MIDODRINE ANS, MIDODRINE SCP, VASODRINE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
247 working days (255)
Active ingredients
midodrine hydrochloride
Registration type
NCE/NBE
Indication
MIDODRINE ANS, MIDODRINE SCP, VASODRINE is indicated in adults for the treatment of severe symptomatic orthostatic hypotension due to autonomic dysfunction when exacerbating factors have been addressed and other forms of treatment remain inadequate.